Insulin degludec biosimilar (Hec)

德谷胰岛素生物类似药（东阳光）

Report date: 2026/05/02 20:00:18

Base Information

Drug NameInsulin degludec biosimilar (Hec)
Drug Alias NameRD15003
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesDongguan City Hec Biological Medicine Res And Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSunshine Lake Pharma Co LtdDongguan City Hec Biological Medicine Res And Development Co LtdYichang Hec Changjiang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A